You are here

  • Home
  • Archive
  • Volume 66, Issue Suppl 2
  • PTH-094 Indirect treatment comparison of ustekinumab versus other biologics in moderate to severe crohn’s disease: a 1-year treatment sequence analysis

Article info

Article menu
Download PDFPDF
Inflammatory Bowel Disease
PTH-094 Indirect treatment comparison of ustekinumab versus other biologics in moderate to severe crohn’s disease: a 1-year treatment sequence analysis

Authors

Citation

Pacou M, Mesana L, Gauthier A, et al
PTH-094 Indirect treatment comparison of ustekinumab versus other biologics in moderate to severe crohn’s disease: a 1-year treatment sequence analysis
Gut 2017;66:A253.

Publication history

  • First published June 17, 2017.
Online issue publication 
November 20, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions